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It has only been in recent years that experiments have been reported which
describe attempts to render dermatophytes resistant in vitro to agents possessing
antifungal activity. Murphy and Rothman (1), Sing (2) and Vilanova and
Casanovas (3) were able to render various species of trichophyton resistant to
fatty acids, namely pelargonic acid, a mixture of caproic, caprylic, capric and
lauric acids and undecylenic acid respectively. In these studies different technics
selected from the numerous available in vitro methods (4) were used. All were,
in principle, fungistatic procedures but there was no consistent pattern as to
the use and suitability of the media and procedures. The investigators were
successful in obtaining a three-fold (2) to seven-fold (1, 3) increase of resistance.
This degree of fastness, low as it is, seems characteristic for antifungal agents
of the series of fatty acids and was higher than that obtained with sulfanilamide
(2), geraniol, citrol, eugenol (3) and 2-hydroxy-stilbamidine (5) to which tn-
chophyton showed no more than a two-fold increase in resistance. In fact, the
claim for 2-hydroxy-stilbamidine was based on observations with M. audouini
where less than a two-fold rise was considered, on a statistical basis, to be sig-
nificant.
In light of the paucity of information available on the development of drug
resistance of the dermatophytes and because the degree of resistance observed
with these organisms seems to be low, it was decided to attempt to determine
whether the order of resistance could be raised by increasing the number of
exposures and whether a difference could be observed between specific antifungal
agents of different chemical groups.
MATERIALS AND METHODS
Two species of dermatophytes, T. mentagrophytes and M. lanosum, as well as
two clinically effective antifungal agents, undecylenic acid and 2-Dimethyl-
amino-6- ((3-diethylaminoethoxy)benzothiazole dihydrochloride (Asterol®), were
employed in all experiments.
In order to standardize the procedure of rendering the organisms resistant to
the antifungal agents, the inoculum, incubation time and type of medium em-
ployed were as nearly alike as possible in all passages. Sabouraud's glucose agar
plates containing decreasing concentrations of the antifungal agent were each
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TABLE 1
Development in vitro of drug resistance of Trichophyton mentagrophytes and Micros porum
lanosum to undecylenic acid
Organism
Inactive Concentration (mcg/cc) After—Passages
0 2 19
T. mentagrophytes
M. lanosum
10.0 40.0 40.0
10.0 40.0 40.0
TABLE 2
Development in vitro of drug resistance of Trichophyton mentagrophytes and Micros porum
lanosum to Asterol
seeded with 2,500,000 conidiospores suspended in 0.5 cc of saline. After an
average incubation period of 14 days at 28°C., the first plate showing full normal
growth was used as an inoculum for the next passage. This qualification is em-
phasized since Asterol causes, in a wide range of concentrations, atypical growth
consisting almost entirely of chiamydospores (6).
RESULTS
In table 1 are given the observations made on the development of drug re-
sistance by T. mentagrophytes and M. lanosum to undecylenic acid. The results
obtained with both organisms are identical. The two species initially grew at a
concentration of 10 mcg/cc. After 2 passages, growth was observed at 40 meg/cc
(four-fold rise in resistance) and no further increase in resistance could be ob-
tained even after an additional 16 passages.
With Asterol, as shown in table 2, a four-fold increase in resistance from
0.125 mcg/cc to 0.5 mcg/cc was obtained with T. mentagrophytes after 3 passages.
By the seventh passage this organism no longer responded to 1.0 meg/cc and
in the next, or eighth, passage it had reached maximum resistance and grew in
2.0 meg/cc. No further increase over this sixteen-fold rise of resistance could be
obtained even though a total of 28 passages over a period of one year was car-
ried out.
The pattern observed with M. lanosum was essentially the same as that seen
with T. mentagrophytes. The organism showed normal growth initially at a
concentration of 0.0625 meg/cc. After 2 passages a two-fold increase of resist-
ance resulted. By the third passage the organism was insensitive to 0.5 meg/cc
(eight-fold rise) and by the fifth passage to 1 meg/cc (sixteen-fold rise). Maxi-
mum resistance of a thirty-two-fold increase was reached in the thirteenth
passage when growth was observed in a concentration of 2.0 meg/cc Asterol.
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No further increase was seen even though an additional 15 passages were em-
ployed.
DISCUSSION
The original observations of Murphy and Rothman (1), Sing (2) and Vilanova
and Casonovas (3) that dermatophytes can be made resistant to the fatty acids
and that this resistance is of a low order is confirmed by the present studies.
Results of a similar nature were also obtained with 2-Dimethy1amino-6-(f-di-
ethylaminoethoxy)benzothiazole dihydrochioride (Asterol). The somewhat
greater degree of resistance observed with Asterol may possibly be due to two
factors. The first is that this substance offers a much larger range of concentra-
tions within which it may develop resistance. Secondly, the increase of resistance
occurs only within that range of concentrations in which atypical growth nor-
mally develops (6). Resistance to a fully fungistatic concentration was not
observed.
SUMMARY
1. Development of resistance to undecylenic acid and 2-Dimethylamino-6-
(3-diethylaminoethoxy)benzothiazo1e dihydrochioride (Asterol) could be ac-
complished in vitro with both Trichophyton mentagrophytes and Microsporum
lanosum.
2. The degree of resistance was of a relatively low order, four-fold with Un-
decylenic acid and sixteen- to thirty-two-fold with Asterol.
3. These experiments are in no way suggestive that therapeutic failure in the
treatment of dermatophytes is due to drug resistance of the fungi, an observation
which has apparently not been made clinically.
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